Table 5.
Analyte | LOQ (ng·mL−1) | Linearity (n = 3 Different Days) | ||
---|---|---|---|---|
Linear Range (ng·mL−1) | r ± SD | g ± SD | ||
ZEN | 1.0 | 1–200 | 0.994 ± 0.002 | 12 ± 4 |
AZEL | 1.0 | 1–200 | 0.996 ± 0.002 | 13 ± 4 |
AZAL | 1.0 | 1–200 | 0.996 ± 0.001 | 16 ± 3 |
BZAL | 0.5 | 0.5–200 | 0.995 ± 0.003 | 19 ± 2 |
BZEL | 0.5 | 0.5–200 | 0.995 ± 0.003 | 16 ± 4 |
ZAN | 1.0 | 1–200 | 0.998 ± 0.002 | 14 ± 4 |
TeA | 1.0 | 1–200 | 0.996 ± 0.002 | 19 ± 1 |
AOH | 2.0 | 2–200 | 0.998 ± 0.001 | 18 ± 1 |
AME | 1.0 | 1–200 | 0.997 ± 0.002 | 17 ± 4 |
DON | 1.0 | 1–200 | 0.992 ± 0.002 | 15± 3 |
DOM1 | 1.0 | 1–200 | 0.995 ± 0.001 | 15 ± 2 |
3/15ADON | 0.5 | 0.5–200 | 0.994 ± 0.003 | 18 ± 1 |
T2 | 0.5 | 0.5–200 | 0.998 ± 0.001 | 16 ± 5 |
AFB1 | 1.0 | 1–200 | 0.993 ± 0.002 | 12 ± 3 |
AFM1 | 0.5 | 0.5–200 | 0.996 ± 0.003 | 13 ± 2 |
OTA | 1.0 | 1–200 | 0.996 ± 0.001 | 14 ± 5 |
ENNA1 | 0.5 | 0.5–200 | 0.995 ± 0.002 | 15 ± 3 |
ENNA | 0.5 | 0.5–200 | 0.997 ± 0.002 | 18 ± 2 |
ENNB | 0.5 | 0.5–200 | 0.997 ± 0.001 | 12 ± 7 |
ENNB1 | 1 | 1–100 | 0.995 ± 0.003 | 10 ± 2 |
BEA | 0.5 | 0.5–200 | 0.993 ± 0.001 | 15 ± 3 |
FB1 | 1.0 | 1–200 | 0.995 ± 0.002 | 17 ± 3 |
FB2 | 1.0 | 1–200 | 0.998 ± 0.001 | 11 ± 5 |
Note: SD, standard deviation; acceptance criteria: r ≥ 0.990 and g ≤ 20%.